Showing results (1191-1200 of 1,404) with videos related to
Sort By:
Pageof 141
Pharmacology Research & Perspectives|September 20, 2022
Prescribing cascades in community-dwelling adults: A systematic reviewAnn S Doherty, Faiza Shahid, Frank Moriarty, et al.Pharmacology Research & Perspectives|September 1, 2022
Metabolic clearance of select opioids and opioid antagonists using hepatic spheroids and recombinant cytochrome P450 enzymesWing Y Tuet, Samuel A Pierce, Matthieu Conroy, et al.Pharmacology Research & Perspectives|December 27, 2023
A descriptive pharmacokinetic/pharmacodynamic analysis of ceftazidime-avibactam in a case series of critically ill patients with augmented renal clearanceYing Xu, Jian Tang, Binbin Yuan, et al.Pharmacology Research & Perspectives|March 16, 2024
Preclinical metabolism and the disposition of vornorexant/TS-142, a novel dual orexin 1/2 receptor antagonist for the treatment of insomniaYoshihiro Konno, Shunsuke Kamigaso, Hidetoh Toki, et al.Pharmacology Research & Perspectives|March 2, 2024
Identification and neuroprotective properties of NA-184, a calpain-2 inhibitorMichel Baudry, Yubin Wang, Xiaoning Bi, et al.Pharmacology Research & Perspectives|January 23, 2024
Scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of RUNX2 proteinYing Wu, Pan GongPharmacology Research & Perspectives|July 20, 2024
Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistanceNaoki Okamoto, Kenta Yagi, Sayaka Imawaka, et al.Pharmacology Research & Perspectives|July 25, 2024
Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoringLing Shu, Ben-Nian Huo, Nan-Ge Yin, et al.Pharmacology Research & Perspectives|July 17, 2024
Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospectsIgor Rubinić, Marija Kurtov, Robert LikićPharmacology Research & Perspectives|July 10, 2024
Has the human biological interaction with SARS-CoV2 variants entered a pliant "Faustian bargain"?Richard J Head, Marko Popovic, Jennifer H MartinPageof 141